{"name":"ImCheck Therapeutics","slug":"imcheck-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPaDhOUmhLVVFmbnlhNU5JeUtsZTVzeGR3ZE1SSTJfd3pPX180R3VNa0I2ZmYtbHFYNkNUOE5Yc256Q1g0Ukpzb3p4NUt3LUxBV1JvU0Vic3Rvc05oQWZ5bzR2d3NBaWMyYVZtU3d1QzU2NDRIVFpMSENUeFlxRDRWNFNUeC1OeVl3QWdMaFFUM21jbFk1RFVvWXl6YlFTc2hOOW5pdkZSUUxDazNZTGNFM1R5WjllV25jVGxTS0wwRk9JUQ?oc=5","date":"2025-12-15","type":"pipeline","source":"Ipsen","summary":"Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline - Ipsen","headline":"Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1CeHFPNUFmUWdoUzM1dGVxd2xQR002Yi1pVnpMWWlFNkhPcmpNRGk1Ry1tOWhuMXdTWW94NmF3QU4xRGpEalJtVGxPTDNlbkNPczZvQkNMeWlackIwZGhjOGN3U3FTak9OZWdPNDNXaHotRVRWQ1RTZDh4cU1NOXM?oc=5","date":"2025-10-23","type":"deal","source":"Pharmaceutical Technology","summary":"Ipsen agrees to buy French biotech company ImCheck - Pharmaceutical Technology","headline":"Ipsen agrees to buy French biotech company ImCheck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQT1dFcU1YR21SNjlNN1Z2Rjl4T3p3YnVudnRic0JUNzR6czh5UzR0RlBpZThKQTl2ZVU0SWE0QlhjS3h3ekVqR1FadXZSQmZZZ3RxQzhtODZ1dml6aFVHRkdtbW5Xblp4aHFQdTFNZy1Nd1JXTGpnXzFmNjVvX0oxVWVNd2VmcDBfQ1ZBenllQkxGUWlzdWltTGJXVzI?oc=5","date":"2025-10-23","type":"deal","source":"PMLiVE","summary":"Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn - PMLiVE","headline":"Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQNlRrRWkzdWZ5XzRVVGcxeUZJaXJJVlNrbEU2akgxODltUC1UUWRzV2xBMTVJLU1mSFB5RmVEYVUtY0xVbzhjMDZPZzZTZDl5eFEyQVhrcmtHalBteW8yZzJOSlZQZHhfZFRCRlZFTElaM2xCTW1SY2hLakF4aUxQNWYxVWgtdnV3VEtPRm1GT0hycEJrVlFtVlRHY3FxSklj?oc=5","date":"2025-10-22","type":"deal","source":"Fierce Biotech","summary":"Ipsen writes check worth up to €1B to acquire next-gen cancer biotech - Fierce Biotech","headline":"Ipsen writes check worth up to €1B to acquire next-gen cancer biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNdFRTWmJkX0dMRkVkYkJvYzk5WUxjeXBxbzA4dkhqaE1DSTVuRExKSjl2bW53Q3BpV1o5UHI3blBkdnJ6Z2F1UjE0b05PWHNUQUdDMWNScnVOUDlBc1N5cXpMX3NMOG1ubk5rb0xDUS1jczBZdU8zUTM3bk9XdjJMM19PbV9rbGk4QjdxUERSMGVZdXFld3Nsc1gyajQ4ZV9neC1haEJyWENrUVdhVU94VWdVLXc4NE00WG5UeFoyNjdERzFIZVZ6LQ?oc=5","date":"2025-10-22","type":"deal","source":"European Pharmaceutical Review","summary":"Ipsen strikes €1bn deal to acquire French biotech ImCheck Therapeutics - European Pharmaceutical Review","headline":"Ipsen strikes €1bn deal to acquire French biotech ImCheck Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNV2puNmlmN1V4OHhHM2VZQkhMaEMwRV93UlB0REdRX3pJcFcyRC1wU2h4Z0ptcXhmcm1DRUswbGRSY2pkUjdaN2diOWQ1eTVxeXk2T3BfRk01VlEwNzhVckc4UXVEWXQxaHlvVUtkcFcyMGhmb3pJN1NiNV9pYk9udzlUMG53cUU?oc=5","date":"2025-10-22","type":"deal","source":"pharmaphorum","summary":"Ipsen buys ImCheck, adding mid-stage leukaemia drug - pharmaphorum","headline":"Ipsen buys ImCheck, adding mid-stage leukaemia drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBqWnJxZWpuR0FBZ2gtRWZ6S0lYUThxT2JLWThCQWtVaEpWaFp6bkZoSDRtdkoyQ2dZWVJKLXRIQThLeERJbzlYSEJaTDVkVnFfWnU4?oc=5","date":"2025-10-22","type":"pipeline","source":"FirstWord Pharma","summary":"Ipsen splashes up to €1B on ImCheck and its lead cancer drug - FirstWord Pharma","headline":"Ipsen splashes up to €1B on ImCheck and its lead cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOVFBBMnF4cUFTUi13cllQZmZBbS1UWno1RlA5RjdkRWxKQTJxX3IzMEcyS0pwY2ZnbGd0U0dLbmV3VThnMXpab0UzaGdsUWhWTF9LaHpTX0RoWndZQ0xBQUZSaURSd1Y3QzlEMXp6NnZ0MHFuVk5rSFZ3R1prTk9nRnliRnp1cER4dnVIcmZQbGVoeUpjY0U0c1ZDN0FjSzR4SV9GWXdJSUpoSUdBamItcmRTVVd1OUdaN3lrQ0xYeHBMdHJPV2N2akE3ZDVvSG8tRTJnMWhn?oc=5","date":"2025-10-22","type":"deal","source":"Cision News","summary":"EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion - Cision News","headline":"EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPdVRhNGdrMkFremE3TGZmakQ4QXJDWms3cFE3MEVXTTh2dkNWU1E4VU9fckh2N3FaQTRwdk9odzB4R2NZVWpNOWg4cllUSmlUd1FxMWZHQVRaTXVIRmFaZk51RGloR25tX1NScV93ams1bVI1M0FraUdCdTRES1JtSnlQc0JLMlBQQXZ2VHBWQ0taLUdyY0Jr?oc=5","date":"2025-10-22","type":"trial","source":"Endpoints News","summary":"Ipsen to buy ImCheck for €350M to get ‘superfamily’ of immunotherapies - Endpoints News","headline":"Ipsen to buy ImCheck for €350M to get ‘superfamily’ of immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFA5UXdyUkxTX2Q0WGxKeG1FV3BNMk1VTHBYOENfeVJYYS11Q3AzeXptandmVHRXMVFWRUd4U2JwazVMQ1ZJN0U1QmtLajdnNjdVNVBJTFVsQzRUUmVOQzhoek54R0ZxX282Tm9sLXRnYjBEWm9iR044?oc=5","date":"2025-10-22","type":"deal","source":"USA Herald","summary":"Ipsen to acquire ImCheck Therapeutics For €1B - USA Herald","headline":"Ipsen to acquire ImCheck Therapeutics For €1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOeWdXTHNYSEM5WldDb3pBVGJibUlkb2NjZjZhTTR6NmFlcWhadlg4amdDTGpXTzJ2Uk5va1U2ZGpLVFRaWWY3aFlqdnYwSTBRN2YzQVJhbWJGM3dBbV8tVHZDV1pGMWVmd1RZTFVRdHBQWGthMjdJRTBfajFvRXBxLVdLdEpxLXJoUHZFZw?oc=5","date":"2025-10-22","type":"deal","source":"European Biotechnology Magazine","summary":"Ipsen acquires ImCheck in US$1bn deal - European Biotechnology Magazine","headline":"Ipsen acquires ImCheck in US$1bn deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQOWN0Rng0Unh6WFNxTUpwajhOZTBWM1VFbFROaERSem5sWjk1VTROUDY5SnEzalRxMmpoRDFsUVBCLVMyZDRvQlRWdVBNdU1maERRWWtFV242RkwtSGNHODdWZl9jV0VvN2dWQXFQNk01cFI5NmVXM0l4d2h5b256UkNjekgtM215UkVpRHBlWExkYlZZ?oc=5","date":"2025-10-21","type":"deal","source":"Yahoo Finance","summary":"Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline - Yahoo Finance","headline":"Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}